Provision of Micronutrient-Fortified Food From 6 Months of Age Does Not Permit HIV-Exposed Uninfected Zambian Children to Catch Up in Growth to HIV-Unexposed Children: A Randomized Controlled Trial
Authors:
- Suzanne FilteauSFSuzanne Filteau
- Kathy BaisleyKBKathy Baisley
- Molly ChisengaMCMolly Chisenga
- Lackson KasonkaLKLackson Kasonka
- Rosalind S GibsonRGRosalind S Gibson
Open Access
- 1 February 2011
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 56 (2) , 166-175
Abstract
HIV-exposed, uninfected (HIV-EU) children represent a large proportion of children in southern Africa. The reasons for their poorer growth and higher morbidity and mortality than their HIV-unexposed peers are unclear. We compared anthropometry of 125 HIV-EU with 382 HIV-unexposed young Zambian children participating in a trial of micronutrient-fortified complementary/replacement food. The randomized controlled trial provided children from age 6 to 18 months with a porridge flour containing either a basal or a rich level of micronutrients. Weight and length were measured 3 monthly and head and arm circumferences and triceps and subscapular skinfolds 6 monthly. There were no significant anthropometric differences between the 2 treatment groups. In unadjusted analyses, most anthropometric Z scores of HIV-EU children were lower than those of HIV-unexposed children; after adjustment for treatment arm, socioeconomic factors, breastfeeding and sex, head and arm circumference Z scores remained lower. Subscapular skinfold Z scores were lower among HIV-EU than HIV-unexposed children at 6 months but not 18 months. Socioeconomic factors accounted for some but not all of the impaired growth of HIV-EU children. Micronutrient malnutrition may not be the socioeconomic factor responsible for the growth faltering. Factors acting earlier in life had irreversible effects.Keywords
This publication has 18 references indexed in Scilit:
- Universal Antiretroviral Therapy for Pregnant and Breast‐Feeding HIV‐1–Infected Women: Towards the Elimination of Mother‐to‐Child Transmission of HIV‐1 in Resource‐Limited SettingsClinical Infectious Diseases, 2009
- The HIV‐exposed, uninfected African childTropical Medicine & International Health, 2009
- Fortified complementary foods with or without α-amylase treatment increase hemoglobin but do not reduce breast milk intake of 9-mo-old Zambian infantsThe American Journal of Clinical Nutrition, 2007
- Child Mortality According to Maternal and Infant HIV Status in ZimbabweThe Pediatric Infectious Disease Journal, 2007
- Early growth of infants of HIV‐infected and uninfected Zambian womenTropical Medicine & International Health, 2007
- Acceptability, storage stability and costing of α‐amylase‐treated maize–beans–groundnuts–bambaranuts complementary blendJournal of the Science of Food and Agriculture, 2007
- Developmental potential in the first 5 years for children in developing countriesThe Lancet, 2007
- Where and why are 10 million children dying every year?The Lancet, 2003
- Growth of children according to maternal and child HIV, immunological and disease characteristics: a prospective cohort study in Kinshasa, Democratic Republic of CongoInternational Journal of Epidemiology, 1999
- Growth of human immunodeficiency type 1-infected and uninfected children: a prospective cohort study in Kigali, Rwanda, 1988 to 1993The Pediatric Infectious Disease Journal, 1996